This is an outdated version published on 2022-06-25. Read the most recent version.

Anti- receptor NMDA encephalitis, a diagnosis to consider


Authors

DOI:

https://doi.org/10.22517/25395203.24916

Keywords:

Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Encephalitis, Psychosis, Autoimmune Diseases

Abstract

Encephalitis are inflammatory brain disorders that are secondary to different pathological processes that include infectious and autoimmune causes. In recent years, the autoimmune processes involved have been studied with an increment in the identification of cases that present a wide variety of neurological and psychiatric symptoms, which often make their timely diagnosis difficult. This is a narrative review that describes the main aspects of encephalitis caused by antibodies against the N-methyl-D-aspartate receptor (NMDAR), its pathogenesis (mechanism shared with psychotic disorders), diagnosis, and clinical presentation; these are aspects that highlight the importance of a thorough evaluation of psychiatric manifestations in the clinical setting.

Downloads

Download data is not yet available.

Author Biographies

Giovanny Armando Argoty Chamorro, Md., Fundación Universitaria Ciencias de la Salud

Médico.

Especialista en psiquiatría, Fundación Universitaria Ciencias de la Salud.

Laura Melissa Rodríguez López, Md., Fundación Universitaria de Ciencias de la Salud

Médica.

Especialista en psiquiatría. Fundación Universitaria de Ciencias de la Salud

Carlos Edgardo Rodríguez Angarita, Md., Fundación Universitaria de Ciencias de la Salud

Médico cirujano.

Especialista en Psiquiatría.

Especialista en Epidemiología.

Jefe de la División de Salud Mental, Fundación Universitaria de Ciencias de la Salud.

Downloads

Published

2022-02-14 — Updated on 2022-06-25

Versions

How to Cite

Argoty Chamorro, G. A., Rodríguez López, L. M., & Rodríguez Angarita, C. E. (2022). Anti- receptor NMDA encephalitis, a diagnosis to consider. Revista Médica De Risaralda, 28(1). https://doi.org/10.22517/25395203.24916 (Original work published February 14, 2022)